TLDR Trinity Biotech stock rises 1.87% after $7M Perceptive Advisors investment news. Trinity Biotech regains Nasdaq bid price compliance after 10-day qualifying streak. Trinity Biotech secures $2.5M in new debt and $4.5M in capitalised interest. Trinity Biotech eyes CGM+ growth ...